Literature DB >> 3763675

The interaction of rifamycin-SV with the hepatic transport and sulfation of taurolithocolic acid in rats.

P Bonazzi, G Novelli, R Galeazzi.   

Abstract

Sulfated and non sulfated lithocholic acid were analyzed in serum, bile and urine of bile-fistula Sprague-Dawley female rats by gas-liquid chromatography and thin-layer chromatography. In rats (group A) bile was collected during a 3 h saline infusion followed by a 3 h intravenous infusion of taurolithocholate; animals of group B and C were infused with both taurolithocholate and rifamycin-SV, but in the animals of group C the renal pedicles were ligated. Serum bile acids showed a significant increase only in animals of group C, during the infusion of rifamycin-SV. In bile of animals of group A sulfated lithocholic acid represented 18% of total, but was not found in bile of animals of group B and C, while a significant increase of sulfated lithocholic acid was evident in urine of animals of group B. The results indicate that rifamycin-SV probably interferes with the hepatic secretion of sulfated lithocholic acid in the rat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3763675     DOI: 10.1016/0031-6989(86)90110-4

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN: 0031-6989


  2 in total

1.  Effect of topical rifamycin SV treatment on cyclosporin A blood levels in a renal transplant recipient.

Authors:  E Renoult; J Hubert; P Trechot; D Hestin; M Kessler; J L'Hermite
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.